New scalp formula shows promise for hair regrowth in small study
NCT ID NCT07615608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair density using scalp images. The goal was to see if the formula could improve hair regrowth and scalp health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Dec 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Adults aged 18 years or older Diagnosis of androgenetic alopecia Candidates for hair restoration procedures Exclusion Criteria: Active scalp infection or inflammatory scalp disease Cicatricial alopecia or severe scalp pathology Uncontrolled systemic disease or unstable medical condition Pregnancy or breastfeeding Immunosuppressive therapy hypersensitivity to any component of the investigational device
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alopecia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biointelligent Technology Syst
Barcelona, 08009, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria supplement tested against chemo hair loss
- Can a scalp gel turn back male pattern baldness?
- Can a serum plus a red light cap regrow hair?
- Scalp cancer surgery that leaves hair follicles behind
- Can a Four-Times-a-Year injection regrow hair in men?
- Can a vitamin pill reverse hair loss from Weight-Loss drugs?